Video

Cristi Radford on the Nurse Navigator's Role in Genetic Counseling

Cristi Radford, a Certified Genetic Counselor, explains the multifaceted role that oncology nurse navigators play in the genetic counseling process.

Cristi Radford, MS, CGC, Certified Genetic Counselor, Genetic Education Program, Sarasota Memorial Hospital, explains the multifaceted role that oncology nurse navigators play in the genetic counseling and cancer risk assessment process.

Radford believes that nurse navigators are able to impact genetic counseling the most in the community setting, since this is where many patients are diagnosed and treated. As one of the first individuals to interact with a patient, the nurse navigator should look for signs of a hereditary symptom in order to determine if the patient is a good candidate for genetic counseling or risk assessment. If the navigator feels the patient's cancer is hereditary they can advise the treatment team and the patient to seek genetic counseling.

Nurse navigators may also be tasked with addressing many of the myths associated with genetic counseling and cancer risk assessment. Patients have many questions regarding their insurance and possible discrimination that nurse navigators may need to answer first in order to move forward with the risk assessment process.

<<<

View more from the 2012 NCONN Conference

Related Videos
J. Bradley Elder, MD
Rimas V. Lukas, MD
Diane Reidy-Lagunes, MD, vice chair, Oncology Operations, Regional Care Network, Memorial Sloan Kettering Cancer Center
Yelena Y. Janjigian, MD, chief, Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center
Paolo Caimi, MD
Jennifer Scalici, MD
Steven H. Lin, MD, PhD
Anna Weiss, MD, associate professor, Department of Surgery, Oncology, associate professor, Cancer Center, University of Rochester Medicine
Roy S. Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology), professor, pharmacology, deputy director, Yale Cancer Center; chief, Hematology/Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital; assistant dean, Translational Research, Yale School of Medicine
Victor Moreno, MD, PhD